US 9441019
Influenza hemagglutinin protein-based vaccines
granted A61KA61K2039/55555A61K2039/55566
Quick answer
US patent 9441019 (Influenza hemagglutinin protein-based vaccines) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/55555, A61K2039/55566, A61K2039/575, A61K2039/6031